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This study investigated possible growth-inhibiting effects of bee venom applied alone or in combination 
with a cytotoxic drug bleomycin on HeLa and V79 cells in vitro based on clone formation, cell counting, 
and apoptosis. Melittin, the key component of bee venom, is a potent inhibitor of calmodulin activity, 
and also a potent inhibitor cell growth and clonogenicity. Intracellular accumulation of melittin correlates 
with the cytotoxicity of antitumour agents. Previous studies indicated that some calcium antagonists 
and calmodulin inhibitors enhanced intracellular levels of antitumor agents by inhibiting their outward 
transport. In this study, treatment of exponentially growing HeLa and V79 cells with bleomycin caused a 
dose-dependent decrease in cell survival due to DNA damage. This lethal effect was potentiated by adding 
a non-lethal dose of the bee venom. By preventing repair of damaged DNA, bee venom inhibited recovery 
from potentially lethal damage induced by bleomycin in V79 and HeLa cells. Apoptosis, necrosis, and 
lysis were presumed as possible mechanisms by which bee venom inhibited growth and clonogenicity of 
V79 cells. HeLa cells, on the other hand, showed greater resistance to bee venom. Our fi ndings suggest 
that bee venom might fi nd a therapeutic use in enhancing cytotoxicity of antitumour agent bleomycin.
KEY WORDS: apoptosis, cell line, cytotoxic drug, growth inhibition, melittin
Oršolić N. CYTOTOXICITY OF BEE VENOM
Arh Hig Rada Toksikol 2009;60:317-326
Many studies have reported about natural products 
inhibiting tumour cell growth and metastasis, as well 
as inducing apoptosis, bringing hope of improved 
treatment of human tumours (1-5). Bee venom has 
traditionally been used to relieve pain and to treat 
chronic infl ammatory diseases such as rheumatoid 
arthritis. It has also been used by oriental traditional 
medicine (6), and in recent times in the treatment of 
tumours (1-4, 7).
Bee venom plays a major role in the defence of 
bee colonies. It is produced in the venom gland of 
the bee, located in the abdominal cavity. It is a very 
complex mixture of active peptides, enzymes, and 
amines that contains histamine, catecholamines, 
polyamines, melittin, and phospholipase A
2 
(7-10). 
The key component of bee venom is melittin, which 
makes 50 % of its dry weight. It is a strong basic 
polypeptide whose sequence consists of 26 amino 
acids (molecular weight 2850 Da) (7-10). It has 
strong haemolytic and cardiotoxic properties (7, 11, 
12) and has been shown to revert the phenotype of 
H-ras-transformed cells (13). Hait et al. demonstrated 
that melittin was one of the most potent inhibitors of 
calmodulin activity and a more potent inhibitor of cell 
growth and clonogenicity than phenothiazines. (14-
17). Drugs that inhibit calmodulin activity have been 
shown to inhibit DNA synthesis in the glioblastoma 
cell line (18), block the movement of chromosomes 
during metaphase (19), inhibit the growth of Chinese 
hamster ovary cells (20), and enhance the cytotoxicity 
of vincristine, doxorubicin, and bleomycin (21-23). 
Evidence also suggests that calmodulin inhibitors are 
cytotoxic to malignant cells both in vitro (14, 24) and 
in vivo (1, 2, 25, 26). In addition, bee venom induces 
single- and double-strand DNA breaks in human 
lymphocytes (27).
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In this study we investigated the effects of bee 
venom on the growth and clonogenicity HeLa and V79 
cells. We also considered possible use of bee venom in 
enhancing the cytotoxicity of antitumour agents.
MATERIALS AND METHODS
Bee venom
Lyophilised whole bee venom was purchased from 
Medex (Ljubljana, Slovenia). It was reconstituted in 
0.5 mL of distilled water and centrifuged at 12,000 
rpm for 10 min to remove insoluble materials. The 
resulting solutions were administered to cell cultures 
in concentrations 0.7125 µg mL-1, 1.425 µg mL-1, 
2.85 µg mL-1, 7.125 µg mL-1 or 14.25 µg mL-1 
according to design described below.
Bleomycin
Bleomycin formulated for clinical use was obtained 
from Heinrich Mack Nachf (Illertissen, Germany). 
It was used at doses of 25 µg mL-1, 50 µg mL-1 or 
100 µg mL-1.
Unless specified otherwise, the rest of the 
chemicals and reagents used were purchased form 
Sigma Chemical Co (St. Louis, USA).
Cell lines
The experiments were performed on human 
cervical carcinoma cells (HeLa) and Chinese hamster 
lung fi broblasts (V79). The average doubling time in 
log phase was about 20 h for HeLa cells and 12 h for 
V79 cells. Cells were grown in monolayer cultures 
in plastic disposable Petri dishes (Falcon) in minimal 
essential medium supplemented with 10 % foetal calf 
serum. Cell cultures were incubated at 37 °C in humid 




Cells were counted using Coulter Counter (Model 
B, Coulter Electronics, Dunstable, England). Petri 
dishes with different concentrations of the studied 
compounds were incubated for 72 h. Growth medium 
was then removed, and cells rinsed with phosphate-
buffered saline (PBS), trypsinised, diluted, and 
counted in triplicate.
Colony formation
Exponentially growing HeLa and V79 cells were 
treated with various concentrations of bee venom for 
24 h. After treatment, the bee venom was removed, 
and the cultures washed twice with PBS. Cells were 
trypsinised, and their survival determined by colony 
formation as described elsewhere (20). Cells were 
immediately plated on culture dishes in triplicate and 
propagated in culture for 8 to 10 days to evaluate the 
ability of the treated cells to form colonies. Colonies 
were stained with 10 % Giemsa and counted. A cell 
was considered to have retained reproductive capacity 
(survival) if it gave rise to a colony of 50 or more cells. 
The results were expressed as percent of colonies of 
untreated cells. The plating effi ciency of the untreated 
control culture was 65 %.
Survival studies for simultaneous treatment with 
bleomycin and bee venom
Exponentially growing HeLa and V79 cells were 
treated for 1 h with various concentrations of bleomycin 
alone (25 µg mL-1to 100 µg mL-1) dissolved in fresh 
medium or with bleomycin in combination with 
bee venom. After treatment, both compounds were 
removed, and cultures washed twice with PBS. Cells 
were trypsinised, and survival determined by colony 
formation (20). Cells were then counted and seeded 
into Petri dishes (100 cells per dish). After 10 days, 
the medium was removed and cells stained with 10 % 
Giemsa. Colonies containing 50 cells or more were 
scored and results expressed as the survival index. 
The index was calculated by dividing the number of 
colonies formed per plate by the total number of singe 
cells initially seeded per plate.
Effect of bee venom on recovery from 
bleomycin-induced cell damage
Exponentially growing cells were treated with 
bleomycin (100 µg mL-1) for 1 h. The drug was 
then removed and cultures washed twice with PBS. 
One group of cells was immediately processed for 
colony formation, with no time allowed for recovery. 
Replicate plates were treated with fresh medium alone 
or fresh medium containing bee venom in various 
concentrations. The cultures were then incubated at 
37 °C and allowed to recover for 3 h. At appropriate 
times, replicate plates were removed and prepared 
for colony formation. Cell survival was determined 
as described above.
Apoptosis analysis
Apoptosis was determined using bivariant fl ow 
cytometry (28) on cells that were grown in the 
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presence or absence of bee venom for 3 h or 15 h , 
respectively. The cells were washed in cold PBS twice 
and resuspended in a small volume of 1x binding 
buffer (HEPES containing 2.5 mmol L-1 CaCl
2
). 
Fluorescein-labelled annexin V and propidium iodide 
(PI) were added to the cells, which were then analysed 
using fl ow cytometry.
Staining with PI allowed for determination of 
DNA content in the tested cells. For that purpose, 
the cells were incubated in 100 µL of fi xing solution 
at 4 °C for 15 min, washed in PBS, resuspended in 
permeabilising solution in the presence of 10 µL of 
PI, and incubated at 4 °C for 15 min. The cells were 
then washed with PBS and immediately analysed 
using fl ow cytometry.
Statistics
Results are expressed as means ± SE obtained 
from two or three experiments in triplicate. Statistical 
signifi cance was evaluated using the Student’s t-test.
RESULTS
Bee venom cytotoxicity
Growth inhibitory effect of bee venom administered 
in various concentrations to HeLa and V79 cells was 
estimated by counting their number after 72 h of 
treatment. Figure 1 shows the infl uence of bee venom 
on the growth of the tested cells.
Growth inhibition by bee venom was dose-
dependent in both cell lines. IC
50 
for HeLa cells was 
3 µg mL-1. The inhibitory effect on V79 cells was more 
pronounced, and the same dose of bee venom killed 
about 90 % of V79 cells.
As for colony-forming, V79 cells treated in 
exponentially growing phase were more sensitive to 
the adverse effects of bee venom administered for 24 
h than HeLa cells (Figure 2).
Potentiation of bleomycin lethality by bee venom
Treatment of exponentially growing cells with 
the DNA damaging agent bleomycin caused a dose-
dependent decrease in cell survival. This lethal effect 
was potentiated by a nonlethal dose (2.85 µg mL-1) 
of bee venom (Figure 3). Bee venom enhanced toxic 
effects of bleomycin (25 µg mL-1 to 100 µg mL-1) 
on HeLa cells from 27 % to 58 %. In presence of 
bee venom, 55 % of the V79 cells were killed at 
bleomycin dose of 25 µg mL-1, and increasing the
dose of bleomycin to 100 µg mL-1 resulted in a further 
79 % decrease in cell survival.
Figure 1  Growth curves of V79 and HeLa cells treated with bee venom. Cells were seeded (1´105 per Petri dish) and incubated 
for 24 h before bee venom was added. Treatment with bee venom lasted for the next 72 h and then the cells were 
counted. The results are expressed in percentages with respect to untreated cells. Each point represents the mean 
number of cells from triplicate cultures from a representative of three experiments. There was less than 10 % variation 
in cell counts at each point.
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Effect of bee venom on recovery from 
bleomycin-induced damage
Figure 4 shows how bee venom affected recovery 
from bleomycin-induced damage based on increased 
survival observed when cells were exposed to various 
concentrations of bee venom after a single exposure 
to a bleomycin. HeLa and V79 cells were recovering 
in a fresh medium, and the addition of bee venom 
to the medium at concentrations of 0.7125 µg mL-1, 
1.425 µg mL-1, or 2.85 µg mL-1 not only inhibited 
recovery, but also resulted in a signifi cant increase 
Figure 2  Survival of proliferating V79 and HeLa cells exposed to increasing concentrations of bee venom for 24 h . Cells were 
seeded for colonies and treated with bee venom. Colonies were stained with 10 % Giemsa. Colonies containing 50 or 
more cells were counted and counts were expressed as percent of colonies of untreated cells. Each point represents 
the mean number of colonies from triplicate cultures from a representative of three experiments. There was less than 
10 % variation in colony counts at each point.
Figure 3  Dose-response curves of exponentially growing V79 and HeLa cells treated with various concentrations of bleomycin 
(25 µg mL-1 to 100 µg mL-1) or bleomycin and bee venom (2.85 µg mL-1) for 1 h. After treatment, their survival was 
determined by colony formation. Colonies were stained with 10 % Giemsa and counted. A cell was considered to have 
retained reproductive capacity (survival) if it gave rise to a colony of 50 or more cells. The survival index was derived 
by dividing the number of colonies formed per plate by the total number of single cells initially seeded per plate.
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(p<0.05, p<0.01, p<0.001) in the number of killed 
HeLa cells within the fi rst three hours. Similar effects 
were observed in experiments with V79 cells (Figure 
4).
Apoptosis and necrosis assay
The effect of bee venom (1.425 µg mL-1 or 
2.25 µg mL-1) on HeLa cells that were treated for 3 h 
or 15 h was evaluated using fl ow cytometry (Figure 
5). Early stage of apoptosis started three hours after 
the treatment of HeLa cells with bee venom. In control 
HeLa cells early stage apoptosis was recorded for 
2.15 % of cells, whereas in the culture treated with 
1.425 µg mL-1 of bee venom for three hours it was 
recorded for 6.18 % of cells. Apoptosis in HeLa 
cells treated with bee venom for 15 h was 7.79 % 
versus 4.09 % in the control line. We also observed 
a slight increase in the number of necrotic cells both 
after 3 h and 15 h of HeLa cell incubation with bee 
venom. Early stage apoptosis and necrosis of V79 
cells was not determined. Instead, we determined the 
percentage of cells in A
0
, which is an indicator of late 
apoptosis (Figure 6). Apoptosis in V79 cells treated 
with 1.425 µg mL-1 of bee venom for 3 h was 13.14 % 
versus 5.6 % in the control line, while apoptosis in 
V79 cells treated for 15 h was lower than control 
(Figure 6).
DISCUSSION
The results of our study provide an additional 
support to previous reports on antitumour activity of 
melittin in vitro (1, 4, 15-17). Melittin was a more 
potent inhibitor of calmodulin activity and growth of 
L1210 cells, C6 astrocytoma, and human and murine 
leukaemic cells than trifl uoperazine or chlorpromazine. 
Weiss et al. (29, 30) demonstrated that phenothiazines 
and structurally similar drugs were binding to and 
inhibiting calmodulin activity.
Our study shows that bee venom inhibits cell 
growth, cell proliferation, and clonogenicity of 
V79 and HeLa cells, possibly through inhibition of 
calmodulin (Figures 1 and 2). Our results suggest that 
V79 cells are more sensitive to calmodulin inhibitors 
and the lytic effect of bee venom than HeLa cells. This 
effect may be owed to differences in average doubling 
time in the log phase between V79 and HeLa cells 
(12 h for V79 cells and about 20 h for HeLa cells), 
differences in membrane topography, and differences 
Figure 4  Effect of bee venom on recovery from bleomycin-induced damage. Exponentially growing V79 and HeLa cells were 
treated with bleomycin (100 µg mL-1) for 1 h. After treatment, one group of cells was immediately processed for colony 
formation, with no time allowed for recovery. Other cells were treated with bee venom in various concentrations. 
Cultures were then incubated at 37 °C and allowed to recover for 3 h. At appropriate times, replicate plates were 
removed and prepared for colony formation. Cell survival was determined as described in methods.
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in cell calcium and magnesium levels. In addition, V79 
cells are rich in amino-group/carbohydrate binding 
sites, which also bind melittin (31).
We also observed differences in the growth curves 
of HeLa and V79 cells treated with bee venom. Since 
the number of cells in a culture is a measure of both 
cell proliferation and death, growth inhibition by 
calmodulin inhibitors could be due to the inhibition 
of proliferation rather than to cytotoxicity, which is in 
line with our results. Balk et al. (32) strongly suggest 
that both calcium and magnesium play signifi cant roles 
in triggering cell replication. However, other evidence 
indicates that extracellular calcium is necessary for 
DNA synthesis and cell proliferation in normal cells, 
but not in cancer cells (33).
The mechanism by which bee venom exerts 
anticalmodulin activity and inhibits cell growth is 
unknown. One possible mechanism might be the 
inhibition of a calmodulin-sensitive enzyme such as 
cyclic nucleotide phosphodiesterase. Inhibition appears 
to be mediated by the formation of a calcium-dependent 
high-affi nity complex of calmodulin and melittin (34-
37). Although phosphodiesterase was the fi rst enzyme 
demonstrated to be activated by calmodulin, it is now 
known that numerous enzymes and structural proteins 
depend on this pervasive calcium-binding protein 
(38, 39). Calmodulin is essential for many processes 
in normal cell function, including the assembly and 
disassembly of microtubules, calcium extrusion 
from cells by a calcium-magnesium ATPase, and 
activation of numerous intracellular enzymes such as 
protein kinases, phosphatases, and cyclic nucleotide 
phosphodiesterase (38, 39). Interference with any of 
these known functions of calmodulin could be toxic 
to cells. Other cell functions affected by calmodulin 
inhibitors may or may not be mediated exclusively 
by calmodulin inhibition. These effects include 
depletion of intracellular ATP (40), destabilisation 
of the membranes (1, 10, 13, 14), and inhibition of 
protein kinase C.
Our data indicate that bee venom inhibits DNA 
repair and that this may be the mechanism by which 
it increases bleomycin lethality and inhibits recovery 
from bleomycin-induced damage (Figures 3 and 4). 
Several mechanisms may explain our fi ndings. Firstly, 
effl ux of antitumor agents from cells may be controlled 
by calcium and calmodulin (calcium-calmodulin 
complex), and calmodulin inhibitors could directly 
inhibit the calcium-calmodulin complex. Secondly, 
permeability of cell membranes might be perturbed 
by bee venom or by changes in calcium environment. 
Thirdly, the affi nity of bleomycin for intracellular 
targets may be altered by calcium antagonist-induced 
changes in calcium environment or by calmodulin 
inhibitors.
In this study, we have shown that bee venom might 
result in apoptosis and/or necrosis of HeLa and V79 
cells. Bee venom caused dose- and time-dependent 
changes in V79 cells, but not in HeLa cells (Figures 5 
and 6). The absence of apoptosis or necrosis in HeLa 
cells remains unexplained, and calls for a long-term 
study with bee venom. It is also possible that melittin 
as a Ca2+ antagonist also blocks the Ca2+ channel, 
and offers complete protection against cell death. In 
Figure 6  Induction of apoptosis in V79 and HeLa cells by 
bee venom. Cells were cultured in the absence or 
presence of bee venom (1.425 µg mL-1) for 3 h or 
15 h, washed, fixed, permeabilised, and stained 
with propidium iodide and then analysed by fl ow 
cytometry.
Figure 5  Induction of apoptosis and necrosis in HeLa cells 
by bee venom. Cells were cultured in the absence 
or presence of bee venom (1.425 µg mL-1) for 3 h or 
15 h, washed and stained with fl uorescein-labelled 
annexin V and propidium iodide and then analysed 
by fl ow cytometry.
Oršolić N. CYTOTOXICITY OF BEE VENOM

















certain cell lines it was demonstrated that Ca2+ channel 
blockers stop apoptosis or necrosis and thus reduce 
DNA damage (41). Studies with well-known Ca2+ 





, may help to clarify this question.
Most examples of apoptosis are accompanied by 
signifi cant cytosolic and nuclear Ca2+accumulation 
and Ca2+/Mg2+ endonuclease activation. However, 
there is a growing evidence showing no increase in 
intracellular Ca2+ (42) and no early appearance of 
internucleosomal DNA fragments characteristic of 
Ca2+/Mg2+ endonuclease activation (43-45). Although 
these reports argue that Ca2+/Mg2+endonuclease 
fragmentation of DNA may not always be involved 
in apoptosis, and that, when present, it may be a 
relatively late molecular event, they did not dismiss 
other forms of DNA damage, such as detachment of 
duplex DNA loops from the nuclear scaffold and the 
cleavage of DNA into large kilobase and megabase 
fragments, as important early events in the stereotype 
changes in DNA morphology. Although the role of 
Ca2+ in early chromatin disruption is ambiguous, DNA 
damage remains the leading candidate for initiating 
apoptotic cell death.
The underlying mechanisms of apoptosis are 
largely unknown. A recent study by Tu et al. (46) 
demonstrated anticancer effects of bee venom in 
human melanoma A2058 cells and its mode of action 
at the cellular and molecular levels. The authors found 
that honeybee venom induced calcium-dependent 
but caspase-independent apoptotic cell death in 
human melanoma A2058 cells, but not in normal 
skin fi broblast Detroit 551 cells. They suggested 
that treatment of A2058 cells with melittin, the key 
component of bee venom, resulted in similar elevation 
of calcium levels and cell death (47). Observations 
by Ip et al. (48) indicated that bee venom induced 
cell cycle arrest and apoptosis in human cervical 
epidermoid carcinoma Ca Ski cells via a Fas 
receptor pathway, involving mitochondrial-dependent 
pathways, and that it is closely related to the level of 
cytoplasmic Ca2+ in Ca Ski cells. Flow cytometry in 
their study showed that bee venom induced reactive 
oxygen species, increased the level of cytoplasmic 
Ca2+, reduced mitochondrial membrane potential 
which led to cytochrome c release, and promoted the 
activation of caspase-3 which then led to apoptosis. 
Bee venom also induced an increase in the levels of 
Fas, p53, p21 and Bax, but a decrease in the level of 
Bcl-2. The activities of both caspase-8 and caspase-9 
were enhanced by bee venom, promoting caspase-3 
activation and leading to DNA fragmentation. Apart 
from the caspase-dependent pathway, these authors 
also suggested a caspase-independent pathway 
through expression of apoptosis-inducing factor (AIF) 
and endonuclease G (Endo G) in the Ca Ski cells. A 
similar mechanism of bee venom was confi rmed in 
human breast cancer MCF7 cells (49), U937 cells 
(50), and in human MG63 osteosarcoma cells (47). 
Data by Wang et al. (51) suggest that melittin can 
synergize with TRAIL in the induction of human 
hepatocellular carcinoma cell (HCC) apoptosis, and 
that the combination of melittin with tumour necrosis 
factor (TNF)-related apoptosis-inducing ligand 
(TRAIL) may be a promising therapeutic approach in 
the treatment of TRAIL-resistant human cancer.
In summary, this study suggests that proliferation 
and clonogenicity of V79 and HeLa cells in culture 
with the bee venom is not entirely due to the inhibition 
of calmodulin, and that the cytotoxic effect of bee 
venom could partially be related to its apoptotic and 
necrotic activities. This study also points to possible 
new ways to use bee venom to improve the cytotoxic 
effects of antitumour, calmodulin-inhibiting agents.
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Sažetak
POVEĆANJE LETALNOG UČINKA BLEOMICINA NA STANICE HeLa I V79 S POMOĆU 
PČELINJEG OTROVA
U uvjetima in vitro istražen je inhibitorni učinak pčelinjeg otrova, samog ili združenog s citostatikom 
bleomicinom, na rast stanica HeLa i V79. Rabljene su sljedeće metode: brojenje stanica, metoda klonskog 
rasta i apoptoza. Poznato je da neki antagonisti kalcija i kalmodulinski inhibitori povisuju unutarstaničnu 
razinu protutumorskih lijekova inhibirajući njihov prijenos iz stanice. Unutarstanična akumulacija melitina 
izravno povećava citotoksični učinak protutumorskog lijeka. Obrada stanica HeLa i V79 u eksponencijalnoj 
fazi rasta bleomicinom uzrokuje oštećenje DNA ovisno o dozi te smanjenje broja živih stanica. Uočeno 
je da se letalni učinak bleomicina može pojačati dodatkom neletalne doze pčelinjeg otrova. Pčelinji otrov 
pritom inhibira popravak nastalih oštećenja u stanicama HeLa i V79 te sprječava oporavak stanica tretiranih 
bleomicinom. Apoptoza, nekroza i liza mogući su mehanizmi kojima pčelinji otrov inhibira rast i stvaranje 
kolonija stanica V79, dok HeLa-stanice pokazuju pojačanu otpornost na pčelinji otrov. Istraživanje također 
potvrđuje mogućnost uporabe pčelinjeg otrova u povećanju citotoksičnosti bleomicina.
KLJUČNE RIJEČI: apoptoza,  citotoksičnost, inhibicija rasta, melitin, stanične linije 
CORRESPONDING AUTHOR:
Nada Oršolić
Department of Animal Physiology
Faculty of Science, University of Zagreb
Rooseveltov trg 6, 10 000 Zagreb, Croatia
E-mail: norsolic@yahoo.com
Oršolić N. CYTOTOXICITY OF BEE VENOM
Arh Hig Rada Toksikol 2009;60:317-326
